Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/1996
05/30/1996WO1996016041A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines
05/30/1996WO1996016036A1 18-nor-vitamin d compounds
05/30/1996WO1996016035A1 18,19-dinor-vitamin d compounds
05/30/1996WO1996016027A1 Matrix metalloprotease inhibitors
05/30/1996WO1996015816A2 Stable n-terminally linked dtpa:protein compositions and methods
05/30/1996WO1996015810A1 Monofunctional and/or polyfunctional polylysine conjugates
05/30/1996WO1996015808A1 Method for making a medicament for treating secondary immunodeficiency
05/30/1996WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
05/30/1996WO1996015781A1 Use of nitric oxide-releasing agents for reducing metastasis risk
05/30/1996WO1996015778A1 Polynucleotide compositions
05/30/1996DE19541284A1 Verfahren zur Immunmodulation Methods for immunomodulation
05/30/1996CA2206876A1 18,19-dinor-vitamin d compounds
05/30/1996CA2206873A1 18-nor-vitamin d compounds
05/30/1996CA2205807A1 Fusion proteins with cytotoxic activity against cells overexpressing erbb2-4
05/30/1996CA2205593A1 Enzyme gene therapy catalysing prodrug extracellular conversion
05/30/1996CA2205486A1 Polynucleotide compositions
05/30/1996CA2204438A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
05/29/1996EP0713870A1 Novel fused indan derivative and pharmaceutically acceptable salt thereof
05/29/1996EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them
05/29/1996EP0713396A1 Medical use of stem bromelain protease
05/29/1996EP0639179B1 23-oxa derivatives of d-series vitamins, method of preparing them, pharmaceutical preparations containing them, and the use of such preparations as drugs
05/29/1996EP0415924B1 Regulation of cell proliferation and differentiation using peptides
05/29/1996CN1123548A Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents
05/29/1996CN1123547A Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
05/29/1996CN1123280A Novel pyrrolocarbazoles
05/29/1996CN1123185A Immune couplet
05/29/1996CN1123157A "Zuliudan"-medicine for resisting tumor and production technology thereof
05/29/1996CN1031878C Process for preparing mono and bis alkylamino anthracyclines
05/28/1996US5521284 Human cancer inhibitory pentapeptide amides and esters
05/28/1996US5521194 Antiproliferative agent for restenosis treatment
05/28/1996US5521185 Methods for inhibiting graft rejection and IL-1 production
05/28/1996CA2078996C A bifunctional dtpa-type ligand
05/25/1996CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/23/1996WO1996015238A1 Targeted t lymphocytes
05/23/1996WO1996015234A2 Lipid-splitting enzyme
05/23/1996WO1996015222A1 HUMAN MutT2
05/23/1996WO1996015143A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH
05/23/1996WO1996015131A1 Macrocyclic lactone compounds and their production process
05/23/1996WO1996015128A2 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
05/23/1996WO1996015118A1 Aniline derivatives
05/23/1996WO1996015101A1 Novel amino acid derivatives with improved multi-drug resistance activity
05/23/1996WO1996015096A1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
05/23/1996WO1996014880A1 Method and apparatus for interstitial radiation of the prostate gland
05/23/1996WO1996014877A1 Novel tumor suppressor gene, hic-1
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996014872A1 Novel complexes and their compositions
05/23/1996WO1996014856A1 Cancer inhibitory peptides
05/23/1996WO1996014852A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna)
05/23/1996WO1996014745A1 Eleutherobin and analogs thereof
05/23/1996CA2224198A1 Novel amino acid derivatives with improved multi-drug resistance activity
05/23/1996CA2205414A1 Novel tumor suppressor gene, hic-1
05/23/1996CA2205019A1 Novel complexes and their compositions
05/23/1996CA2204908A1 Lipid cleavage enzyme
05/23/1996CA2203934A1 Targeted t lymphocytes
05/23/1996CA2203565A1 Synthesis of peptide nucleic acids (pnas) and analogues via submonomer approach
05/22/1996EP0712863A1 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
05/22/1996EP0712629A1 Acyl deoxyribonucleoside derivatives and uses thereof
05/22/1996EP0712390A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
05/22/1996EP0712315A1 Radiometal complexes that localise in hypoxic tissue
05/22/1996EP0712313A1 Pro-cytotoxic drug conjugates for anticancer therapy
05/22/1996EP0712312A1 Suppression of inhibitors
05/22/1996EP0673376B1 Bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds
05/22/1996EP0637299B1 20-methyl-substituted vitamin d derivates
05/22/1996EP0486526B1 Tumour necrosis factor binding ligands
05/22/1996CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
05/22/1996CN1122693A Medical use of RNA from poultry embryo
05/21/1996US5519163 Inhibitors of phosphoinositide-specific phospholipase C
05/21/1996US5519155 Platinum complexes
05/21/1996US5519117 Polypeptide sequences as anticarcinogenic agents
05/21/1996US5519053 5-Iodo-6-amino-1,2-Benzopyrones and their metabolites useful as cytostatic agents
05/21/1996US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them
05/21/1996US5519018 Substituted phenols and their use for the treatment of disorders caused by cell proliferation
05/21/1996US5519005 Guanidine terminated peptides for treatment of thrombosis, antitumor agents, autoimmune diseases and immunology
05/21/1996US5518999 Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability
05/21/1996US5518911 Human PAK65
05/18/1996CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
05/17/1996WO1996014340A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014334A1 IDENTIFICATION OF THE p21WAF1-PCNA INTERACTION SITE AND THERAPEUTIC APPLICATIONS THEREOF
05/17/1996WO1996014329A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014309A1 Taxane derivatives
05/17/1996WO1996014308A1 Taxane derivatives
05/17/1996WO1996014087A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996WO1996014073A1 Treatment of urogenital cancer with boron neutron capture therapy
05/17/1996WO1996014065A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/17/1996WO1996010639A3 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
05/17/1996WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
05/17/1996CA2307311A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996CA2204380A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996CA2204361A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/17/1996CA2203909A1 Identification of the p21waf1-pcna interaction site and therapeutic applications thereof
05/15/1996EP0711829A2 Recombinant alphavirus vectors
05/15/1996EP0711785A1 Novel antitumor antibiotic compounds: hayumicins and analogs thereof
05/15/1996EP0711767A1 Antineoplastic cyclolignan derivatives
05/15/1996EP0711557A1 Base for formulating pharmaceutical agents
05/15/1996EP0711556A1 Intravenous solutions containing staurosporine derivatives
05/15/1996EP0711355A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
05/15/1996EP0711345A1 B7-2: ctl a4/cd 28 counter receptor
1 ... 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 ... 2211